Greenwich LifeSciences, Inc. (GLSI) › Operating Cash FlowGreenwich LifeSciences, Inc. (GLSI) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2019: -$293.3K2020: -$1.15M2021: -$4.29M2022: -$6.20M2023: -$6.48M2024: -$7.27M2025: -$9.91M-$9.91M2019Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$9.91M-36.4%2024-$7.27M-12.2%2023-$6.48M-4.5%2022-$6.20M-44.5%2021-$4.29M-272.2%2020-$1.15M-293.1%2019-$293.3K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share